| Q28272538 | A point mutation at the X-chromosomal proteolipid protein locus in Pelizaeus-Merzbacher disease leads to disruption of myelinogenesis |
| Q52170605 | A proteolipid protein-specific pre-mRNA (Ppm-1) contains intron 3 and is up-regulated during myelination in the CNS. |
| Q52172815 | Abnormal expression of neurofilament proteins in dysmyelinating axons located in the central nervous system of jimpy mutant mice. |
| Q71664232 | Analysis of myelin proteolipid protein and F0 ATPase subunit 9 in normal and jimpy CNS |
| Q48972525 | Animal models of demyelination |
| Q31051923 | Application of q-Space Diffusion MRI for the Visualization of White Matter. |
| Q35204565 | Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease |
| Q48511250 | DM-20 mRNA Is Expressed During the Embryonic Development of the Nervous System of the Mouse |
| Q31146358 | DM20 mRNA splice product of the myelin proteolipid protein gene is expressed in the murine heart |
| Q48569841 | Delayed and incomplete myelination in a transgenic mouse mutant with abnormal oligodendrocytes |
| Q36589047 | Developmental Regulation of Myelin-Associated Genes in the Normal and the Myelin Deficient Mutant Rat |
| Q30844881 | Diffusion tensor imaging of patients with proteolipid protein 1 gene mutations |
| Q34334046 | Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein |
| Q73575620 | Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant |
| Q36225299 | Enhanced Expression of Trib3 during the Development of Myelin Breakdown in dmy Myelin Mutant Rats |
| Q71567360 | Epigenetic factors up-regulate expression of myelin proteins in the dysmyelinating jimpy mutant mouse |
| Q56896429 | Estimating heritabilities in quantitative behavior genetics: A station passed |
| Q35990827 | Expression of a myelin proteolipid protein (Plp)-lacZ transgene is reduced in both the CNS and PNS of Plp(jp) mice |
| Q41072954 | Expression of molecular chaperones and vesicle transport proteins in differentiating oligodendrocytes |
| Q48600365 | Glycerophosphorylcholine phosphocholine phosphodiesterase activity in cultured oligodendrocytes, astrocytes, and central nervous tissue of dysmyelinating rodent mutants |
| Q48671111 | Hyperactivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy |
| Q43514731 | Immunohistochemical studies on cross-transplantations between jimpy, shiverer, and normal newborn mice |
| Q73098719 | Imprinting as a rapid technique for assessing the morphology of the central nervous system by immunofluorescence |
| Q38340068 | In vitro death of jimpy oligodendrocytes: correlation with onset of DM-20/PLP expression and resistance to oligodendrogliotrophic factors |
| Q45028407 | Increased NG2(+) glial cell proliferation and oligodendrocyte generation in the hypomyelinating mutant shiverer |
| Q73002671 | Initiation of sodium channel clustering at the node of Ranvier in the mouse optic nerve |
| Q56140215 | Insensitivity of the analysis of variance to heredity-environment interaction |
| Q71664227 | Isolation and identification of proteolipid proteins in jimpy mouse brain |
| Q28274588 | Major Myelin proteolipid: the 4-alpha-helix topology |
| Q36616433 | Molecular Genetics of X-Linked Mutants |
| Q40418136 | Molecular genetic analyses of myelin deficiency and cerebellar ataxia. |
| Q48357457 | Mouse models of myelin diseases |
| Q42826232 | Mutant Plp/DM20 cannot be processed to secrete PLP-related oligodendrocyte differentiation/survival factor |
| Q24296775 | Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder |
| Q42794199 | Myelin basic protein is affected by reduced synthesis of myelin proteolipid protein in the jimpy mouse |
| Q41667103 | Nonstructural protein NS2 of parvovirus H-1 is required for efficient viral protein synthesis and virus production in rat cellsin vivo andin Vitro |
| Q73087694 | Normal temporal and spatial distribution of oligodendrocyte progenitors in the myelin-deficient (md) rat |
| Q41679250 | Oligodendrocytes in female carriers of the jimpy gene make more myelin than normal oligodendrocytes |
| Q48450124 | Oligodendrogenesis is differentially regulated in gray and white matter of jimpy mice |
| Q24563063 | Pelizaeus-Merzbacher disease: a valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid |
| Q24678053 | Pelizaeus-Merzbacher disease: an X-linked neurologic disorder of myelin metabolism with a novel mutation in the gene encoding proteolipid protein |
| Q24601977 | Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant |
| Q36714472 | Posttranscriptional Regulation of Myelin Protein Gene Expression |
| Q48665590 | Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. |
| Q24338566 | Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein |
| Q48382385 | Regional and developmental variations of GFAP and actin mRNA levels in the CNS of jimpy and shiverer mutant mice |
| Q52061408 | Structure and Expression of the Mouse Myelin Proteolipid Protein Gene |
| Q40486765 | The Structure and Function of Central Nervous System Myelin |
| Q33869813 | The effect of insulin-like growth factors on brain myelination and their potential therapeutic application in myelination disorders |
| Q39572736 | The genes for myelin revisited |
| Q36221354 | The initial events in myelin synthesis: orientation of proteolipid protein in the plasma membrane of cultured oligodendrocytes |
| Q40488037 | The molecular genetics of myelination: An update |
| Q74587444 | Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse |
| Q55670712 | X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus |